{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:55:13Z","timestamp":1789430113515,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014040","name":"Peer Reviewed Alzheimer\u2019s Research Program","doi-asserted-by":"publisher","award":["AARG-19-616614"],"award-info":[{"award-number":["AARG-19-616614"]}],"id":[{"id":"10.13039\/100014040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41AG06919"],"award-info":[{"award-number":["R41AG06919"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41AG06919"],"award-info":[{"award-number":["R41AG06919"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41AG06919"],"award-info":[{"award-number":["R41AG06919"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41AG06919"],"award-info":[{"award-number":["R41AG06919"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41AG06919"],"award-info":[{"award-number":["R41AG06919"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX004315"],"award-info":[{"award-number":["I01BX004315"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["S10OD010660"],"award-info":[{"award-number":["S10OD010660"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer disease (AD) is the most prevalent cause of dementia in the elderly. Although impaired cognition and memory are the most prominent features of AD, abnormalities in visual functions often precede them, and are increasingly being used as diagnostic and prognostic markers for the disease. Retina contains the highest concentration of the essential fatty acid docosahexaenoic acid (DHA) in the body, and its deficiency is associated with several retinal diseases including diabetic retinopathy and age related macular degeneration. In this study, we tested the hypothesis that enriching retinal DHA through a novel dietary approach could ameliorate symptoms of retinopathy in 5XFAD mice, a widely employed model of AD. The results show that 5XFAD mice have significantly lower retinal DHA compared to their wild type littermates, and feeding the lysophosphatidylcholine (LPC) form of DHA and eicosapentaenoic acid (EPA) rapidly normalizes the DHA levels, and increases retinal EPA by several-fold. On the other hand, feeding similar amounts of DHA and EPA in the form of triacylglycerol had only modest effects on retinal DHA and EPA. Electroretinography measurements after 2\u00a0months of feeding the experimental diets showed a significant improvement in a-wave and b-wave functions by the LPC-diet, whereas the TAG-diet had only a modest benefit. Retinal amyloid \u03b2 levels were decreased by about 50% by the LPC-DHA\/EPA diet, and by about 17% with the TAG-DHA\/EPA diet. These results show that enriching retinal DHA and EPA through dietary LPC could potentially improve visual abnormalities associated with AD.<\/jats:p>","DOI":"10.1038\/s41598-023-36268-0","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T17:00:31Z","timestamp":1686070831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Improvement of retinal function in Alzheimer disease-associated retinopathy by dietary lysophosphatidylcholine-EPA\/DHA"],"prefix":"10.1038","volume":"13","author":[{"given":"Dhavamani","family":"Sugasini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jason","family":"McAnany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xincheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu","family":"Antharavally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Oroskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha A.","family":"Oroskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Layden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Papasani V.","family":"Subbaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"36268_CR1","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1167\/iovs.06-1029","volume":"48","author":"F Berisha","year":"2007","unstructured":"Berisha, F., Feke, G. T., Trempe, C. L., McMeel, J. W. & Schepens, C. L. Retinal abnormalities in early Alzheimer\u2019s disease. Invest. Ophthalmol. Vis. Sci. 48, 2285\u20132289. https:\/\/doi.org\/10.1167\/iovs.06-1029 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"36268_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1176\/appi.ajp.2012.12070940","volume":"170","author":"RG Ross","year":"2013","unstructured":"Ross, R. G. et al. Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk. Am. J. Psychiatry 170, 290\u2013298. https:\/\/doi.org\/10.1176\/appi.ajp.2012.12070940 (2013).","journal-title":"Am. J. Psychiatry"},{"key":"36268_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0039-6257(89)90127-6","volume":"34","author":"B Katz","year":"1989","unstructured":"Katz, B. & Rimmer, S. Ophthalmologic manifestations of Alzheimer\u2019s disease. Surv. Ophthalmol. 34, 31\u201343. https:\/\/doi.org\/10.1016\/0039-6257(89)90127-6 (1989).","journal-title":"Surv. Ophthalmol."},{"key":"36268_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ana.410260208","volume":"26","author":"GL Trick","year":"1989","unstructured":"Trick, G. L., Barris, M. C. & Bickler-Bluth, M. Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. Ann. Neurol. 26, 226\u2013231. https:\/\/doi.org\/10.1002\/ana.410260208 (1989).","journal-title":"Ann. Neurol."},{"issue":"Suppl 1","key":"36268_CR5","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui, M. et al. Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54(Suppl 1), S204-217. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.020 (2011).","journal-title":"Neuroimage"},{"key":"36268_CR6","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s11357-020-00252-7","volume":"42","author":"C Czak\u00f3","year":"2020","unstructured":"Czak\u00f3, C. et al. Retinal biomarkers for Alzheimer\u2019s disease and vascular cognitive impairment and dementia (VCID): Implication for early diagnosis and prognosis. Geroscience 42, 1499\u20131525. https:\/\/doi.org\/10.1007\/s11357-020-00252-7 (2020).","journal-title":"Geroscience"},{"key":"36268_CR7","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1038\/tp.2012.150","volume":"3","author":"S Frost","year":"2013","unstructured":"Frost, S. et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer\u2019s disease. Transl. Psychiatry 3, e233\u2013e233. https:\/\/doi.org\/10.1038\/tp.2012.150 (2013).","journal-title":"Transl. Psychiatry"},{"key":"36268_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/alz.12179","volume":"17","author":"PJ Snyder","year":"2021","unstructured":"Snyder, P. J. et al. Retinal imaging in Alzheimer\u2019s and neurodegenerative diseases. Alzheimers Dement. 17, 103\u2013111. https:\/\/doi.org\/10.1002\/alz.12179 (2021).","journal-title":"Alzheimers Dement."},{"key":"36268_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.biochi.2010.05.005","volume":"93","author":"P Guesnet","year":"2011","unstructured":"Guesnet, P. & Alessandri, J.-M. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS)\u2014Implications for dietary recommendations. Biochimie 93, 7\u201312. https:\/\/doi.org\/10.1016\/j.biochi.2010.05.005 (2011).","journal-title":"Biochimie"},{"key":"36268_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1203\/00006450-199001000-00023","volume":"27","author":"GJ Anderson","year":"1990","unstructured":"Anderson, G. J., Connor, W. E. & Corliss, J. D. Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina. Pediatr. Res. 27, 89\u201397. https:\/\/doi.org\/10.1203\/00006450-199001000-00023 (1990).","journal-title":"Pediatr. Res."},{"key":"36268_CR11","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/S0022-2275(20)41904-2","volume":"32","author":"AM Stinson","year":"1991","unstructured":"Stinson, A. M., Wiegand, R. D. & Anderson, R. E. Recycling of docosahexaenoic acid in rat retinas during n-3 fatty acid deficiency. J. Lipid Res. 32, 2009\u20132017 (1991).","journal-title":"J. Lipid Res."},{"key":"36268_CR12","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0022-2275(20)39729-7","volume":"36","author":"EJ Schaefer","year":"1995","unstructured":"Schaefer, E. J. et al. Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa. J. Lipid Res. 36, 1427\u20131433 (1995).","journal-title":"J. Lipid Res."},{"key":"36268_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.preteyeres.2004.06.002","volume":"24","author":"JP SanGiovanni","year":"2005","unstructured":"SanGiovanni, J. P. & Chew, E. Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res. 24, 87\u2013138. https:\/\/doi.org\/10.1016\/j.preteyeres.2004.06.002 (2005).","journal-title":"Prog. Retin. Eye Res."},{"key":"36268_CR14","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1038\/nutd.2012.10","volume":"2","author":"P Sapieha","year":"2012","unstructured":"Sapieha, P. et al. Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutr. Diabetes 2, e36\u2013e36. https:\/\/doi.org\/10.1038\/nutd.2012.10 (2012).","journal-title":"Nutr. Diabetes"},{"key":"36268_CR15","doi-asserted-by":"publisher","first-page":"e55177","DOI":"10.1371\/journal.pone.0055177","volume":"8","author":"M Tikhonenko","year":"2013","unstructured":"Tikhonenko, M. et al. N-3 polyunsaturated fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function. PLoS ONE 8, e55177. https:\/\/doi.org\/10.1371\/journal.pone.0055177 (2013).","journal-title":"PLoS ONE"},{"key":"36268_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1159\/000441359","volume":"55","author":"EH Souied","year":"2016","unstructured":"Souied, E. H. et al. Omega-3 fatty acids and age-related macular degeneration. Ophthalmic Res. 55, 62\u201369. https:\/\/doi.org\/10.1159\/000441359 (2016).","journal-title":"Ophthalmic Res."},{"key":"36268_CR17","doi-asserted-by":"publisher","first-page":"CD000376\u2013CD0003","DOI":"10.1002\/14651858.CD000376.pub4","volume":"3","author":"B Jasani","year":"2017","unstructured":"Jasani, B., Simmer, K., Patole, S. K. & Rao, S. C. Long chain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst. Rev. 3, CD000376\u2013CD000376. https:\/\/doi.org\/10.1002\/14651858.CD000376.pub4 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"36268_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1159\/000525266","volume":"119","author":"S Diggikar","year":"2022","unstructured":"Diggikar, S., Aradhya, A. S., Swamy, R. S., Namachivayam, A. & Chandrasekaran, M. Effect of enteral long-chain polyunsaturated fatty acids on retinopathy of prematurity: A systematic review and meta-analysis. Neonatology 119, 547\u2013557. https:\/\/doi.org\/10.1159\/000525266 (2022).","journal-title":"Neonatology"},{"key":"36268_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/antiox11010116","volume":"11","author":"P Pi\u00f1as Garc\u00eda","year":"2022","unstructured":"Pi\u00f1as Garc\u00eda, P., Hern\u00e1ndez Mart\u00ednez, F. J., Azn\u00e1rez L\u00f3pez, N., Castill\u00f3n Torre, L. & Tena Sempere, M. E. Supplementation with a highly concentrated docosahexaenoic acid (DHA) in non-proliferative diabetic retinopathy: A 2-year randomized double-blind placebo-controlled study. Antioxidants 11, 116 (2022).","journal-title":"Antioxidants"},{"key":"36268_CR20","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.ophtha.2013.01.005","volume":"120","author":"EH Souied","year":"2013","unstructured":"Souied, E. H. et al. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: The Nutritional AMD Treatment 2 study. Ophthalmology 120, 1619\u20131631. https:\/\/doi.org\/10.1016\/j.ophtha.2013.01.005 (2013).","journal-title":"Ophthalmology"},{"key":"36268_CR21","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3390\/nu13041253","volume":"13","author":"A Garc\u00eda-Layana","year":"2021","unstructured":"Garc\u00eda-Layana, A. et al. A randomized study of nutritional supplementation in patients with unilateral wet age-related macular degeneration. Nutrients 13, 1253. https:\/\/doi.org\/10.3390\/nu13041253 (2021).","journal-title":"Nutrients"},{"key":"36268_CR22","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/life12101481","volume":"12","author":"A Anton","year":"2022","unstructured":"Anton, A. et al. The Effect of oral citicoline and docosahexaenoic acid on the visual field of patients with glaucoma: A randomized trial. Life 12, 1481 (2022).","journal-title":"Life"},{"key":"36268_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nature13241","volume":"509","author":"LN Nguyen","year":"2014","unstructured":"Nguyen, L. N. et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 509, 503\u2013506. https:\/\/doi.org\/10.1038\/nature13241 (2014).","journal-title":"Nature"},{"key":"36268_CR24","doi-asserted-by":"publisher","first-page":"10501","DOI":"10.1074\/jbc.M116.721340","volume":"291","author":"BH Wong","year":"2016","unstructured":"Wong, B. H. et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid (DHA) in eye and is important for photoreceptor cell development. J. Biol. Chem. 291, 10501\u201310514. https:\/\/doi.org\/10.1074\/jbc.M116.721340 (2016).","journal-title":"J. Biol. Chem."},{"key":"36268_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-981-15-6082-8_14","volume":"1276","author":"BH Wong","year":"2020","unstructured":"Wong, B. H. & Silver, D. L. Mfsd2a: A physiologically important lysolipid transporter in the brain and eye. Adv. Exp. Med. Biol. 1276, 223\u2013234. https:\/\/doi.org\/10.1007\/978-981-15-6082-8_14 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"36268_CR26","doi-asserted-by":"publisher","first-page":"105755","DOI":"10.1016\/j.phrs.2021.105755","volume":"171","author":"CL Zhang","year":"2021","unstructured":"Zhang, C. L. et al. Mfsd2a overexpression alleviates vascular dysfunction in diabetic retinopathy. Pharmacol. Res. 171, 105755. https:\/\/doi.org\/10.1016\/j.phrs.2021.105755 (2021).","journal-title":"Pharmacol. Res."},{"key":"36268_CR27","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.3390\/nu12103114","volume":"12","author":"D Sugasini","year":"2020","unstructured":"Sugasini, D., Yalagala, P. C. R. & Subbaiah, P. V. Efficient enrichment of retinal DHA with dietary lysophosphatidylcholine-DHA: Potential application for retinopathies. Nutrients 12, 3114 (2020).","journal-title":"Nutrients"},{"key":"36268_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mnfr.202000059","volume":"64","author":"PCR Yalagala","year":"2020","unstructured":"Yalagala, P. C. R., Sugasini, D., Zaldua, S. B., Tai, L. M. & Subbaiah, P. V. Lipase treatment of dietary krill oil, but not fish oil, enables enrichment of brain eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Mol. Nutr. Food Res. 64, 1. https:\/\/doi.org\/10.1002\/mnfr.202000059 (2020).","journal-title":"Mol. Nutr. Food Res."},{"key":"36268_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","volume":"144","author":"AG Robson","year":"2022","unstructured":"Robson, A. G. et al. ISCEV Standard for full-field clinical electroretinography (2022 update). Doc. Ophthalmol. 144, 165\u2013177. https:\/\/doi.org\/10.1007\/s10633-022-09872-0 (2022).","journal-title":"Doc. Ophthalmol."},{"key":"36268_CR30","doi-asserted-by":"publisher","first-page":"e202000462","DOI":"10.1002\/jbio.202000462","volume":"14","author":"G Ma","year":"2021","unstructured":"Ma, G., Son, T., Kim, T. H. & Yao, X. In vivo optoretinography of phototransduction activation and energy metabolism in retinal photoreceptors. J. Biophotonics 14, e202000462. https:\/\/doi.org\/10.1002\/jbio.202000462 (2021).","journal-title":"J. Biophotonics"},{"key":"36268_CR31","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917 (1959).","journal-title":"Can. J. Biochem. Physiol."},{"key":"36268_CR32","doi-asserted-by":"publisher","first-page":"11263","DOI":"10.1038\/s41598-017-11766-0","volume":"7","author":"D Sugasini","year":"2017","unstructured":"Sugasini, D., Thomas, R., Yalagala, P. C. R., Tai, L. M. & Subbaiah, P. V. Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice. Sci. Rep. 7, 11263. https:\/\/doi.org\/10.1038\/s41598-017-11766-0 (2017).","journal-title":"Sci. Rep."},{"key":"36268_CR33","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198524847.001.0001","volume-title":"Analysis of Longitudinal Data","author":"P Diggle","year":"2002","unstructured":"Diggle, P., Diggle, P. J., Heagerty, P., Liang, K. Y. & Zeger, S. Analysis of Longitudinal Data (Oxford University Press, 2002)."},{"key":"36268_CR34","doi-asserted-by":"publisher","first-page":"e000326","DOI":"10.1136\/bmjophth-2019-000326","volume":"4","author":"E Prokopiou","year":"2019","unstructured":"Prokopiou, E. et al. Omega-3 fatty acids supplementation protects the retina from age-associated degeneration in aged C57BL\/6J mice. BMJ Open Ophthalmol. 4, e000326. https:\/\/doi.org\/10.1136\/bmjophth-2019-000326 (2019).","journal-title":"BMJ Open Ophthalmol."},{"key":"36268_CR35","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1194\/jlr.M090464","volume":"60","author":"PCR Yalagala","year":"2019","unstructured":"Yalagala, P. C. R., Sugasini, D., Dasarathi, S., Pahan, K. & Subbaiah, P. V. Dietary lysophosphatidylcholine-EPA enriches both EPA and DHA in the brain: potential treatment for depression. J. Lipid Res. 60, 566\u2013578. https:\/\/doi.org\/10.1194\/jlr.M090464 (2019).","journal-title":"J. Lipid Res."},{"key":"36268_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000217726","volume":"41","author":"C Schnebelen","year":"2009","unstructured":"Schnebelen, C. et al. Nutrition for the eye: different susceptibility of the retina and the lacrimal gland to dietary omega-6 and omega-3 polyunsaturated fatty acid incorporation. Ophthalmic Res. 41, 216\u2013224. https:\/\/doi.org\/10.1159\/000217726 (2009).","journal-title":"Ophthalmic Res."},{"key":"36268_CR37","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fnins.2020.00862","volume":"14","author":"JKH Lim","year":"2020","unstructured":"Lim, J. K. H. et al. Retinal functional and structural changes in the 5xFAD mouse model of Alzheimer\u2019s disease. Front Neurosci. 14, 862. https:\/\/doi.org\/10.3389\/fnins.2020.00862 (2020).","journal-title":"Front Neurosci."},{"key":"36268_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1167\/iovs.08-2384","volume":"50","author":"SE Perez","year":"2009","unstructured":"Perez, S. E., Lumayag, S., Kovacs, B., Mufson, E. J. & Xu, S. Beta-amyloid deposition and functional impairment in the retina of the APPswe\/PS1DeltaE9 transgenic mouse model of Alzheimer\u2019s disease. Invest. Ophthalmol. Vis. Sci. 50, 793\u2013800. https:\/\/doi.org\/10.1167\/iovs.08-2384 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"36268_CR39","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1038\/s41598-021-84318-2","volume":"11","author":"JJ McAnany","year":"2021","unstructured":"McAnany, J. J. et al. Rod pathway and cone pathway retinal dysfunction in the 5xFAD mouse model of Alzheimer\u2019s disease. Sci. Rep. 11, 4824. https:\/\/doi.org\/10.1038\/s41598-021-84318-2 (2021).","journal-title":"Sci. Rep."},{"key":"36268_CR40","doi-asserted-by":"publisher","first-page":"035002","DOI":"10.1117\/1.NPh.8.3.035002","volume":"8","author":"TH Kim","year":"2021","unstructured":"Kim, T. H., Son, T., Klatt, D. & Yao, X. Concurrent OCT and OCT angiography of retinal neurovascular degeneration in the 5XFAD Alzheimer\u2019s disease mice. Neurophotonics 8, 035002. https:\/\/doi.org\/10.1117\/1.NPh.8.3.035002 (2021).","journal-title":"Neurophotonics"},{"key":"36268_CR41","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.1096\/fj.201800200R","volume":"32","author":"J Hur","year":"2018","unstructured":"Hur, J. et al. Cerebrovascular \u03b2-amyloid deposition and associated microhemorrhages in a Tg2576 Alzheimer mouse model are reduced with a DHA-enriched diet. FASEB J. 32, 4972\u20134983. https:\/\/doi.org\/10.1096\/fj.201800200R (2018).","journal-title":"FASEB J."},{"key":"36268_CR42","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1007\/s00018-016-2295-x","volume":"73","author":"V Gupta","year":"2016","unstructured":"Gupta, V. et al. One protein, multiple pathologies: multifaceted involvement of amyloid \u03b2 in neurodegenerative disorders of the brain and retina. Cell. Mol. Life Sci. 73, 4279\u20134297. https:\/\/doi.org\/10.1007\/s00018-016-2295-x (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"36268_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/ijms21010070","volume":"21","author":"M S\u00e1nchez-Campillo","year":"2019","unstructured":"S\u00e1nchez-Campillo, M. et al. Decreased blood level of MFSD2a as a potential biomarker of Alzheimer\u2019s disease. Int. J. Mol. Sci. 21, 70 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"36268_CR44","doi-asserted-by":"publisher","first-page":"9689","DOI":"10.1523\/jneurosci.1142-19.2019","volume":"39","author":"ES Lobanova","year":"2019","unstructured":"Lobanova, E. S. et al. Disrupted blood-retina lysophosphatidylcholine transport impairs photoreceptor health but not visual signal transduction. J. Neurosci. 39, 9689\u20139701. https:\/\/doi.org\/10.1523\/jneurosci.1142-19.2019 (2019).","journal-title":"J. Neurosci."},{"key":"36268_CR45","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.bbamem.2018.03.030","volume":"1860","author":"S Senapati","year":"2018","unstructured":"Senapati, S. et al. Effect of dietary docosahexaenoic acid on rhodopsin content and packing in photoreceptor cell membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes 1860, 1403\u20131413. https:\/\/doi.org\/10.1016\/j.bbamem.2018.03.030 (2018).","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"36268_CR46","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1126\/science.182.4118.1253","volume":"182","author":"R Benolken","year":"1973","unstructured":"Benolken, R., Anderson, R. E. & Wheeler, T. G. Membrane fatty acids associated with the electrical response in visual excitation. Science 182, 1253\u20131254 (1973).","journal-title":"Science"},{"key":"36268_CR47","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s11745-001-0796-3","volume":"36","author":"BG Jeffrey","year":"2001","unstructured":"Jeffrey, B. G., Weisinger, H. S., Neuringer, M. & Mitchell, D. C. The role of docosahexaenoic acid in retinal function. Lipids 36, 859\u2013871. https:\/\/doi.org\/10.1007\/s11745-001-0796-3 (2001).","journal-title":"Lipids"},{"key":"36268_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/nu10091250","author":"D Milanovic","year":"2018","unstructured":"Milanovic, D. et al. Short-term fish oil treatment changes the composition of phospholipids while not affecting the expression of Mfsd2a omega-3 transporter in the brain and liver of the 5xFAD mouse model of Alzheimer\u2019s disease. Nutrients https:\/\/doi.org\/10.3390\/nu10091250 (2018).","journal-title":"Nutrients"},{"key":"36268_CR49","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4062\/biomolther.2019.046","volume":"27","author":"J Kim","year":"2019","unstructured":"Kim, J. et al. Theracurmin ameliorates cognitive dysfunctions in 5XFAD mice by improving synaptic function and mitigating oxidative stress. Biomol. Ther. 27, 327\u2013335. https:\/\/doi.org\/10.4062\/biomolther.2019.046 (2019).","journal-title":"Biomol. Ther."},{"key":"36268_CR50","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/biomedicines8090326","volume":"8","author":"S-W Shin","year":"2020","unstructured":"Shin, S.-W., Kim, D.-H., Jeon, W. K. & Han, J.-S. 4-Hydroxynonenal immunoreactivity is increased in the frontal cortex of 5XFAD transgenic mice. Biomedicines 8, 326 (2020).","journal-title":"Biomedicines"},{"key":"36268_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1017\/S0007114514000853","volume":"112","author":"PO Rodrigues","year":"2014","unstructured":"Rodrigues, P. O. et al. Influence of feeding graded levels of canned sardines on the inflammatory markers and tissue fatty acid composition of Wistar rats. Br. J. Nutr. 112, 309\u2013319. https:\/\/doi.org\/10.1017\/S0007114514000853 (2014).","journal-title":"Br. J. Nutr."},{"key":"36268_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1017\/S0007114509991334","volume":"103","author":"G Kaur","year":"2010","unstructured":"Kaur, G. et al. Short-term docosapentaenoic acid (22:5 n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in rats. Br. J. Nutr. 103, 32\u201337. https:\/\/doi.org\/10.1017\/S0007114509991334 (2010).","journal-title":"Br. J. Nutr."},{"key":"36268_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/lipd.12115","volume":"54","author":"Y Adkins","year":"2019","unstructured":"Adkins, Y., Laugero, K. D., Mackey, B. & Kelley, D. S. Accretion of dietary docosahexaenoic acid in mouse tissues did not differ between its purified phospholipid and triacylglycerol forms. Lipids 54, 25\u201337. https:\/\/doi.org\/10.1002\/lipd.12115 (2019).","journal-title":"Lipids"},{"key":"36268_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.plefa.2014.05.007","volume":"92","author":"CT Chen","year":"2015","unstructured":"Chen, C. T. & Bazinet, R. P. \u03b2-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels. Prostaglandins Leukot. Essent. Fatty Acids 92, 33\u201340 (2015).","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"36268_CR55","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1194\/jlr.M021386","volume":"53","author":"M Yu","year":"2012","unstructured":"Yu, M. et al. ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3. J. Lipid Res. 53, 494\u2013504. https:\/\/doi.org\/10.1194\/jlr.M021386 (2012).","journal-title":"J. Lipid Res."},{"key":"36268_CR56","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fncel.2019.00428","volume":"13","author":"F De\u00e1k","year":"2019","unstructured":"De\u00e1k, F., Anderson, R. E., Fessler, J. L. & Sherry, D. M. Novel cellular functions of very long chain-fatty acids: Insight from ELOVL4 mutations. Front Cell Neurosci. 13, 428. https:\/\/doi.org\/10.3389\/fncel.2019.00428 (2019).","journal-title":"Front Cell Neurosci."},{"key":"36268_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22094393","volume":"22","author":"HO Kalkman","year":"2021","unstructured":"Kalkman, H. O., Hersberger, M., Walitza, S. & Berger, G. E. Disentangling the molecular mechanisms of the antidepressant activity of omega-3 polyunsaturated fatty acid: A comprehensive review of the literature. Int. J. Mol. Sci. 22, 1. https:\/\/doi.org\/10.3390\/ijms22094393 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"36268_CR58","doi-asserted-by":"publisher","first-page":"100041","DOI":"10.1194\/jlr.TR120000806","volume":"62","author":"RVS Rajala","year":"2021","unstructured":"Rajala, R. V. S. Signaling roles of phosphoinositides in the retina. J. Lipid Res. 62, 100041. https:\/\/doi.org\/10.1194\/jlr.TR120000806 (2021).","journal-title":"J. Lipid Res."},{"key":"36268_CR59","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nm1591","volume":"13","author":"KM Connor","year":"2007","unstructured":"Connor, K. M. et al. Increased dietary intake of -\u00eb-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 13, 868 (2007).","journal-title":"Nat. Med."},{"key":"36268_CR60","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1167\/iovs.17-23523","volume":"59","author":"E Prokopiou","year":"2018","unstructured":"Prokopiou, E. et al. Omega-3 fatty acids supplementation: Therapeutic potential in a mouse model of Stargardt disease. Invest. Ophthalmol. Vis. Sci. 59, 2757\u20132767. https:\/\/doi.org\/10.1167\/iovs.17-23523 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"36268_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 7, 27\u201331 (2016).","journal-title":"J. Basic Clin. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36268-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36268-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36268-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T18:44:35Z","timestamp":1702579475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36268-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36268"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-36268-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"19 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9179"}}